Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2018-2025

Date: Sep 20 2018
|
QYRESEARCH
|
Number of Pages: 93
|
Alternate Text Alternate Text Alternate Text Alternate Text

This report focuses on the global RNA-Based Therapeutics and Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the RNA-Based Therapeutics and Vaccines development in United States, Europe and China.

RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.
RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.
In 2017, the global RNA-Based Therapeutics and Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis

Market segment by Type, the product can be split into
RNA-Based Therapeutics
RNA-Based Vaccines

Market segment by Application, split into
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global RNA-Based Therapeutics and Vaccines status, future forecast, growth opportunity, key market and key players.
To present the RNA-Based Therapeutics and Vaccines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of RNA-Based Therapeutics and Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
           1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (2013-2025)
           1.4.2 RNA-Based Therapeutics
           1.4.3 RNA-Based Vaccines
    1.5 Market by Application
           1.5.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2025)
           1.5.2 Oncology
           1.5.3 Immunology
           1.5.4 Ophthalmology
           1.5.5 Cardiovascular Diseases
           1.5.6 Infectious Diseases
           1.5.7 Genetic Diseases
           1.5.8 Others
    1.6 Study Objectives
    1.7 Years Considered
2 Global Growth Trends
    2.1 RNA-Based Therapeutics and Vaccines Market Size
    2.2 RNA-Based Therapeutics and Vaccines Growth Trends by Regions
           2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Regions (2013-2025)
           2.2.2 RNA-Based Therapeutics and Vaccines Market Share by Regions (2013-2018)
    2.3 Industry Trends
           2.3.1 Market Top Trends
           2.3.2 Market Drivers
           2.3.3 Market Opportunities
3 Market Share by Key Players
    3.1 RNA-Based Therapeutics and Vaccines Market Size by Manufacturers
           3.1.1 Global RNA-Based Therapeutics and Vaccines Revenue by Manufacturers (2013-2018)
           3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Manufacturers (2013-2018)
           3.1.3 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
    3.2 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
    3.3 Key Players RNA-Based Therapeutics and Vaccines Product/Solution/Service
    3.4 Date of Enter into RNA-Based Therapeutics and Vaccines Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
    4.1 Global RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018)
    4.2 Global RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018)
5 United States
    5.1 United States RNA-Based Therapeutics and Vaccines Market Size (2013-2018)
    5.2 RNA-Based Therapeutics and Vaccines Key Players in United States
    5.3 United States RNA-Based Therapeutics and Vaccines Market Size by Type
    5.4 United States RNA-Based Therapeutics and Vaccines Market Size by Application
6 Europe
    6.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2013-2018)
    6.2 RNA-Based Therapeutics and Vaccines Key Players in Europe
    6.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type
    6.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Application
7 China
    7.1 China RNA-Based Therapeutics and Vaccines Market Size (2013-2018)
    7.2 RNA-Based Therapeutics and Vaccines Key Players in China
    7.3 China RNA-Based Therapeutics and Vaccines Market Size by Type
    7.4 China RNA-Based Therapeutics and Vaccines Market Size by Application
8 Japan
    8.1 Japan RNA-Based Therapeutics and Vaccines Market Size (2013-2018)
    8.2 RNA-Based Therapeutics and Vaccines Key Players in Japan
    8.3 Japan RNA-Based Therapeutics and Vaccines Market Size by Type
    8.4 Japan RNA-Based Therapeutics and Vaccines Market Size by Application
9 Southeast Asia
    9.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size (2013-2018)
    9.2 RNA-Based Therapeutics and Vaccines Key Players in Southeast Asia
    9.3 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type
    9.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application
10 India
    10.1 India RNA-Based Therapeutics and Vaccines Market Size (2013-2018)
    10.2 RNA-Based Therapeutics and Vaccines Key Players in India
    10.3 India RNA-Based Therapeutics and Vaccines Market Size by Type
    10.4 India RNA-Based Therapeutics and Vaccines Market Size by Application
11 Central & South America
    11.1 Central & South America RNA-Based Therapeutics and Vaccines Market Size (2013-2018)
    11.2 RNA-Based Therapeutics and Vaccines Key Players in Central & South America
    11.3 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type
    11.4 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application
12 International Players Profiles
    12.1 Alnylam Pharmaceuticals
           12.1.1 Alnylam Pharmaceuticals Company Details
           12.1.2 Company Description and Business Overview
           12.1.3 RNA-Based Therapeutics and Vaccines Introduction
           12.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.1.5 Alnylam Pharmaceuticals Recent Development
    12.2 Arbutus Biopharma
           12.2.1 Arbutus Biopharma Company Details
           12.2.2 Company Description and Business Overview
           12.2.3 RNA-Based Therapeutics and Vaccines Introduction
           12.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.2.5 Arbutus Biopharma Recent Development
    12.3 Arrowhead Pharmaceuticals
           12.3.1 Arrowhead Pharmaceuticals Company Details
           12.3.2 Company Description and Business Overview
           12.3.3 RNA-Based Therapeutics and Vaccines Introduction
           12.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.3.5 Arrowhead Pharmaceuticals Recent Development
    12.4 BioNTech
           12.4.1 BioNTech Company Details
           12.4.2 Company Description and Business Overview
           12.4.3 RNA-Based Therapeutics and Vaccines Introduction
           12.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.4.5 BioNTech Recent Development
    12.5 CureVac
           12.5.1 CureVac Company Details
           12.5.2 Company Description and Business Overview
           12.5.3 RNA-Based Therapeutics and Vaccines Introduction
           12.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.5.5 CureVac Recent Development
    12.6 Dicerna Pharmaceuticals
           12.6.1 Dicerna Pharmaceuticals Company Details
           12.6.2 Company Description and Business Overview
           12.6.3 RNA-Based Therapeutics and Vaccines Introduction
           12.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.6.5 Dicerna Pharmaceuticals Recent Development
    12.7 Regulus Therapeutics
           12.7.1 Regulus Therapeutics Company Details
           12.7.2 Company Description and Business Overview
           12.7.3 RNA-Based Therapeutics and Vaccines Introduction
           12.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.7.5 Regulus Therapeutics Recent Development
    12.8 Marina Biotech
           12.8.1 Marina Biotech Company Details
           12.8.2 Company Description and Business Overview
           12.8.3 RNA-Based Therapeutics and Vaccines Introduction
           12.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.8.5 Marina Biotech Recent Development
    12.9 MiRagen Therapeutics
           12.9.1 MiRagen Therapeutics Company Details
           12.9.2 Company Description and Business Overview
           12.9.3 RNA-Based Therapeutics and Vaccines Introduction
           12.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.9.5 MiRagen Therapeutics Recent Development
    12.10 Moderna Therapeutics
           12.10.1 Moderna Therapeutics Company Details
           12.10.2 Company Description and Business Overview
           12.10.3 RNA-Based Therapeutics and Vaccines Introduction
           12.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)
           12.10.5 Moderna Therapeutics Recent Development
    12.11 Quark Pharmaceuticals
    12.12 Roche
    12.13 Sylentis
13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
           15.1.1 Methodology/Research Approach
                 15.1.1.1 Research Programs/Design
                 15.1.1.2 Market Size Estimation
                 12.1.1.3 Market Breakdown and Data Triangulation
           15.1.2 Data Source
                 15.1.2.1 Secondary Sources
                 15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures
Table RNA-Based Therapeutics and Vaccines Key Market Segments
Table Key Players RNA-Based Therapeutics and Vaccines Covered
Table Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type 2013-2025
Figure RNA-Based Therapeutics Figures
Table Key Players of RNA-Based Therapeutics
Figure RNA-Based Vaccines Figures
Table Key Players of RNA-Based Vaccines
Table Global RNA-Based Therapeutics and Vaccines Market Size Growth by Application 2013-2025 (Million US$)
Figure Oncology Case Studies
Figure Immunology Case Studies
Figure Ophthalmology Case Studies
Figure Cardiovascular Diseases Case Studies
Figure Infectious Diseases Case Studies
Figure Genetic Diseases Case Studies
Figure Others Case Studies
Figure RNA-Based Therapeutics and Vaccines Report Years Considered
Table Global RNA-Based Therapeutics and Vaccines Market Size 2013-2025 (Million US$)
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate 2013-2025 (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2013-2025 (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2013-2018 (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Share by Regions 2013-2018
Figure Global RNA-Based Therapeutics and Vaccines Market Share by Regions 2013-2018
Figure Global RNA-Based Therapeutics and Vaccines Market Share by Regions 2018
Table Market Top Trends
Table Global RNA-Based Therapeutics and Vaccines Revenue by Manufacturers (2013-2018) (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Share by Manufacturers (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Market Share by Manufacturers in 2018
Table Global RNA-Based Therapeutics and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players RNA-Based Therapeutics and Vaccines Product/Solution/Service
Table Date of Enter into RNA-Based Therapeutics and Vaccines Market
Table Mergers & Acquisitions, Expansion Plans
Table Global RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Size Share by Type (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2013-2018)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$)
Table Global RNA-Based Therapeutics and Vaccines Market Size Share by Application (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application in 2017
Figure United States RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$)
Table United States Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$)
Table United States Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018)
Table United States RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$)
Table United States RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018)
Table United States RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$)
Table United States RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018)
Figure Europe RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$)
Table Europe Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$)
Table Europe Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018)
Table Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$)
Table Europe RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018)
Table Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$)
Table Europe RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018)
Figure China RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$)
Table China Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$)
Table China Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018)
Table China RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$)
Table China RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018)
Table China RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$)
Table China RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018)
Figure Japan RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$)
Table Japan Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$)
Table Japan Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018)
Table Japan RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$)
Table Japan RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018)
Table Japan RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$)
Table Japan RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018)
Figure India RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$)
Table India Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$)
Table India Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018)
Table India RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$)
Table India RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018)
Table India RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$)
Table India RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018)
Figure Central & South America RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$)
Table Central & South America Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$)
Table Central & South America Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018)
Table Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$)
Table Central & South America RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018)
Table Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$)
Table Central & South America RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018)
Table Alnylam Pharmaceuticals Company Details
Table Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) (Million US$)
Figure Alnylam Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table Alnylam Pharmaceuticals Recent Development
Table Arbutus Biopharma Company Details
Table Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$)
Figure Arbutus Biopharma Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table Arbutus Biopharma Recent Development
Table Arrowhead Pharmaceuticals Company Details
Table Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$)
Figure Arrowhead Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table Arrowhead Pharmaceuticals Recent Development
Table BioNTech Company Details
Table BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$)
Figure BioNTech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table BioNTech Recent Development
Table CureVac Company Details
Table CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$)
Figure CureVac Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table CureVac Recent Development
Table Dicerna Pharmaceuticals Company Details
Table Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$)
Figure Dicerna Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table Dicerna Pharmaceuticals Recent Development
Table Regulus Therapeutics Company Details
Table Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$)
Figure Regulus Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table Regulus Therapeutics Recent Development
Table Marina Biotech Company Details
Table Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$)
Figure Marina Biotech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table Marina Biotech Recent Development
Table MiRagen Therapeutics Company Details
Table MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$)
Figure MiRagen Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table MiRagen Therapeutics Recent Development
Table Moderna Therapeutics Company Details
Table Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$)
Figure Moderna Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018)
Table Moderna Therapeutics Recent Development
Table Quark Pharmaceuticals Company Details
Table Roche Company Details
Table Sylentis Company Details
Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions (Million US$) 2018-2025
Figure Global RNA-Based Therapeutics and Vaccines Market Size Share by Regions (2018-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Share by Regions in 2025
Figure United States RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD)
Figure Europe RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD)
Figure China RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD)
Figure Japan RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD)
Figure India RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Product (2018-2025) (Million US$)
Figure Global RNA-Based Therapeutics and Vaccines Market Size by Product (2018-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Size by Product in 2025
Table Global RNA-Based Therapeutics and Vaccines Market Size by Application (2018-2025) (Million US$)
Figure Global RNA-Based Therapeutics and Vaccines Market Size by Application (2018-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.